95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-15.79%
Negative revenue growth while OR stands at 2.59%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-16.44%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-17.01%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-17.01%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-17.73%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-21.88%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-21.88%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.02%
Share reduction more than 1.5x OR's 0.12%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-0.01%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-50.24%
Dividend reduction while OR stands at 10.95%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-15.45%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-32.66%
Negative FCF growth while OR is at 110.10%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
5.30%
10Y CAGR of 5.30% while OR is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
17.64%
Positive 5Y CAGR while OR is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-28.00%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
13.22%
Positive long-term OCF/share growth while OR is negative. John Neff would see a structural advantage in sustained cash generation.
54.57%
5Y OCF/share CAGR at 50-75% of OR's 77.40%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
-25.62%
Negative 3Y OCF/share CAGR while OR stands at 7.74%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
18.59%
Positive 10Y CAGR while OR is negative. John Neff might see a substantial advantage in bottom-line trajectory.
235.00%
Positive 5Y CAGR while OR is negative. John Neff might view this as a strong mid-term relative advantage.
-23.01%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
61.85%
Equity/share CAGR of 61.85% while OR is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
29.21%
Positive 5Y equity/share CAGR while OR is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
22.22%
Positive short-term equity growth while OR is negative. John Neff sees a strong advantage in near-term net worth buildup.
46.20%
Dividend/share CAGR of 46.20% while OR is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
91.79%
5Y dividend/share CAGR above 1.5x OR's 17.38%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
76.29%
3Y dividend/share CAGR above 1.5x OR's 34.28%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
57.36%
AR growth well above OR's 35.34%. Michael Burry fears inflated revenue or higher default risk in the near future.
-50.99%
Inventory is declining while OR stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.02%
Positive asset growth while OR is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-0.06%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-4.44%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-11.84%
We cut SG&A while OR invests at 60.06%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.